Details for New Drug Application (NDA): 204733
✉ Email this page to a colleague
NDA 204733 describes BUTALBITAL, ACETAMINOPHEN AND CAFFEINE, which is a drug marketed by Aurolife Pharma Llc, Dr Reddys Labs Sa, Gilbert Labs, Graham Dm, Granules, Hikma, Key Therap, Lannett Co Inc, Lgm Pharma, Mallinckrodt, Novast Labs, Nuvo Pharms Inc, Quagen, Senores Pharms, Taro, Genus, Abhai Llc, Able, Actavis Labs Ut Inc, Alvogen, Anda Repository, Hikma Pharms, Mikart, Mirror Pharms Llc, Nesher Pharms, Specgx Llc, Strides Pharma, Strides Pharma Intl, Sun Pharm Industries, Vintage Pharms, and Watson Labs, and is included in forty-five NDAs. It is available from thirty-six suppliers. Additional details are available on the BUTALBITAL, ACETAMINOPHEN AND CAFFEINE profile page.
The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
The generic ingredient in BUTALBITAL, ACETAMINOPHEN AND CAFFEINE is acetaminophen; butalbital; caffeine. There are sixty-six drug master file entries for this compound. Thirty-six suppliers are listed for this compound. Additional details are available on the acetaminophen; butalbital; caffeine profile page.
Summary for 204733
| Tradename: | BUTALBITAL, ACETAMINOPHEN AND CAFFEINE |
| Applicant: | Aurolife Pharma Llc |
| Ingredient: | acetaminophen; butalbital; caffeine |
| Patents: | 0 |
Pharmacology for NDA: 204733
| Physiological Effect | Central Nervous System Stimulation |
Suppliers and Packaging for NDA: 204733
| Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
|---|---|---|---|---|---|---|---|---|
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 204733 | ANDA | Aurolife Pharma, LLC | 13107-075 | 13107-075-01 | 100 CAPSULE in 1 BOTTLE (13107-075-01) |
| BUTALBITAL, ACETAMINOPHEN AND CAFFEINE | acetaminophen; butalbital; caffeine | CAPSULE;ORAL | 204733 | ANDA | Aurolife Pharma, LLC | 13107-075 | 13107-075-05 | 500 CAPSULE in 1 BOTTLE (13107-075-05) |
Profile for product number 001
| Active Rx/OTC/Discontinued: | RX | Dosage: | CAPSULE;ORAL | Strength | 325MG;50MG;40MG | ||||
| Approval Date: | Sep 26, 2018 | TE: | AA | RLD: | No | ||||
Complete Access Available with Subscription
